Claudia Schmoor

Assessment and comparison of prognostic classification schemes for survival data

Erika Graf, Claudia Schmoor, Willi Sauerbrei et al. · Statistics in Medicine · 1999 · 904 citations

Public Health, Biostatistics, Oncology +13

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Silvio E. Inzucchi, Bernard Zinman, David Fitchett et al. · Diabetes Care · 2017 · 747 citations

Medicine, Pharmacology, Pharmacotherapy +15

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 719 citations

Life Sciences, Hematology, Immunology +14

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

Jens Hoeppner, Florian Lordick, Thomas Brunner et al. · BMC Cancer · 2016 · 353 citations · Full text

Medicine, Oncology, Surgery +17

Central Retinal Artery Occlusion: Local Intra-arterial Fibrinolysis versus Conservative Treatment, a Multicenter Randomized Trial

Martin Schumacher, Bernhard Jurklies, Christine Gall et al. · Ophthalmology · 2010 · 320 citations

Medicine, Ophthalmology, Surgery +9